<p>"What we have here is failure to communicate..."  We discuss more on gene therapy viral vectors and answer a listener question about melatonin supplementation for FSHD</p>

"What we have here is failure to communicate..." We discuss more on gene therapy viral vectors and answer a listener question about melatonin supplementation for FSHD

<p>"What we have here is failure to communicate..." &nbsp;We discuss more on gene therapy viral vectors and answer a listener question about melatonin supplementation for FSHD</p>

What's going on in FSHD, week ending May 7, 2022

MyFSHD is about education and personal empowerment for the worldwide facioscapulohumeral muscular dystrophy (FSHD) community. Here we have discussions and commentary hosted by FSHD researcher Peter Jones, PhD, on many things of interest to the FSHD community. Learn about the science behind the different FSHD therapeutic approaches, FSHD pathology, family genetics and FSHD diagnostics. We will discuss upcoming clinical trials and what to look forward to. You will get to understand how you can be better prepared, become involved, and help contribute to defeating FSHD once and for all.

Share What's going on in FSHD, week ending May 7, 2022

Sign up to save your podcasts

What's going on in FSHD, week ending May 7, 2022

What's going on in FSHD, week ending May 7, 2022